NeoGenomics, Inc. Accounts Payable
NeoGenomics, Inc. (NEO) had Accounts Payable of $20.95 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-07-28
- 2026-06-30: Accounts Payable, Current $20.95M.
- 2026-03-31: Accounts Payable, Current $25.90M.
- 2025-12-31: Accounts Payable, Current $23.09M.
- 2025-09-30: Accounts Payable, Current $22.61M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $20.95M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $25.90M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $23.09M 10-Q · filed 2026-07-28 |
| 2025-09-30 | $22.61M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $27.49M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $16.21M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $21.61M 10-K · filed 2026-02-17 |
| 2024-09-30 | $16.51M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $17.19M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $18.34M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $20.33M 10-K · filed 2025-02-18 |
| 2023-09-30 | $16.82M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $17.91M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $22.71M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $20.51M 10-K · filed 2024-02-20 |
| 2022-09-30 | $13.71M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $16.85M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $20.48M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $17.92M 10-K · filed 2023-02-24 |
| 2021-09-30 | $28.54M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $23.06M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $18.92M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $24.96M 10-K · filed 2022-02-25 |
| 2020-09-30 | $17.73M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $19.20M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $20.45M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $19.57M 10-K · filed 2021-02-25 |
| 2019-09-30 | $18.00M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $16.33M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $16.51M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $17.78M 10-K · filed 2020-02-28 |
| 2018-09-30 | $9.20M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $12.34M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $13.05M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $10.45M 10-K · filed 2019-02-26 |
| 2017-09-30 | $14.82M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $15.59M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $20.58M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $16.78M 10-K · filed 2018-03-13 |
| 2016-09-30 | $13.98M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $13.44M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $15.29M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $12.46M 10-K · filed 2017-03-14 |
| 2015-09-30 | $5.03M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $6.06M 10-Q · filed 2015-07-31 |
| 2015-03-31 | $5.46M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $6.29M 10-K · filed 2016-04-18 |
| 2014-09-30 | $6.29M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $6.08M 10-Q · filed 2014-07-29 |
| 2014-03-31 | $4.70M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $4.18M 10-K · filed 2015-03-03 |
| 2013-09-30 | $3.78M 10-Q · filed 2013-10-30 |
| 2013-06-30 | $3.39M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $2.92M 10-Q · filed 2013-05-13 |
| 2012-12-31 | $3.61M 10-K · filed 2014-02-24 |
| 2012-09-30 | $3.24M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $3.13M 10-Q/A · filed 2012-08-15 |
| 2012-03-31 | $3.32M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $2.53M 10-K · filed 2013-02-21 |
| 2011-09-30 | $2.29M 10-Q · filed 2011-10-25 |
| 2011-06-30 | $2.46M 10-Q/A · filed 2011-08-01 |
| 2010-12-31 | $1.93M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |